Please ensure Javascript is enabled for purposes of website accessibility

Thrombosis & Haemostasis society of Australia and New Zealand

Promote Excellence in clinical care for people with clotting and bleeding disorders.

Education & Training

Lead education and training for scientists and clinicians in the field

Clinical Research

Foster innovation through research, discovery and clinical trials

Policy & Advocacy

Advocate and develop policies that improve health outcomes


Our story

The THANZ was founded following discussions amongst coagulation enthusiasts led by Beng Chong, who had met together for the 1993 annual HSA meeting in Hobart. Until that time, clotters had consoled themselves within a loose association or "club" and the membership of this club was automatically inherited by THANZ...

Member Benefits

Network and learn form clinicians and researchers who are pioneering the industry
Member-only Resources
Access information and resources via our members-only web portal 
Regular Newsletters
Stay up to date with regular news updates delivered directly to your inbox
Access to a community
Access to a highly active and qualified community of professional

Upcoming Events & Workshops

Gerards Restaurant

THANZ 30th Anniversary Dinner

  • THANZ 30th Anniversary Dinner
     October 26, 2024 - October 27, 2024
     7:00 pm - 12:00 am

THANZ Council is delighted to invite its members to the 30th Anniversary Dinner to be held on Saturday26th October at Gerards Bistro in Brisbane

THANZ Scientific Workshop 2024

  •  October 26, 2024
     8:00 am - 5:00 pm

The THANZ Scientific Workshop is for THANZ and non-THANZ members alike; clinicians, scientists and researchers working in the fields of thrombosis and haemophilia. These interactive coagulation workshops are held under the banner of THANZ each year on the eve of the Blood meeting. Previous workshops have been held in New Zealand and all six Australian […]

Latest news

IVIg use for Heparin induced thrombocytopenia (HIT) and Vaccine induced thrombotic thrombocytopenia (VITT)

The National Blood Authority (NBA) has approved the inclusion of 5 indications of Heparin induced thrombocytopenia (HIT) in the Criteria for the clinical use of immunoglobulin in Australia (th...

National COVID-19 Clinical Evidence Taskforce Guidelines

The COVID-19 Vaccine Claims Scheme is being extended The COVID-19 Vaccine Claims Scheme is due to close on 17 April 2024. However, following the Mid-Year Economic and Fiscal Outlook (MYEFO) update ...

ARES Study published

The THANZ Anticoagulation Reversal and Events Study (ARES) Collaborative has recently published the results of the ARES Study. The paper is available here

2023 S&E Research Grants Awarded

This year THANZ awarded S&E Research Grants to the following members Gabriella Pennings (ANZAC Research Institute/Sydney Local Health District)Mechanism/s of acute IL-1β release...

2023 S&E Travel Grants Awarded

This year THANZ awarded 4 S&E Travel Grants to the following members Yvonne Kong who will travel to the University of Pavia, Italy Hannah Stevens will travel to the University of...

National Statement for the Emergency Use of Group O Red Blood Cells

The National Blood Authority is pleased to advise that the National Statement for the Emergency Use of Group O Red Blood Cells is now available on the National Blood Authority’s we...

Our Sponsors

2024 Corporate Sponsor

THANZ receives financial assistance from the following corporate supporter
© 2024
 Thrombosis & Haemostasis Society of Australia and New Zealand